Salvage Robot-assisted Renal Surgery for Local Recurrence After Surgical Resection or Renal Mass Ablation: Classification, Techniques, and Clinical Outcomes.

Journal: European urology
Published Date:

Abstract

BACKGROUND: Salvage treatment for local recurrence after prior partial nephrectomy (PN) or local tumor ablation (LTA) for kidney cancer is, as of yet, poorly investigated.

Authors

  • Alberto Martini
    University of Genoa, Italy.
  • Filippo Turri
    Department of Urology, University of Modena and Reggio Emilia, Modena, Italy.
  • Ravi Barod
    Specialist Centre for Kidney Cancer Royal Free Hospital, London, UK.
  • Bernardo Rocco
    Department of Urology, University of Central Florida College of Medicine and Global Robotics Institute, Florida Hospital-Celebration Health, Celebration, FL, USA.
  • Umberto Capitanio
    Unit of Urology, Division of Experimental Oncology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy.
  • Alberto Briganti
    Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, URI, IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
  • Francesco Montorsi
    Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, URI, IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
  • Alexandre Mottrie
    ORSI Academy Melle Belgium.
  • Ben Challacombe
  • Brunolf W Lagerveld
    Department of Urology, Onze Lieve Vrouwe Gasthuis (OLVG), Amsterdam, The Netherlands.
  • Karim Bensalah
    Department of Urology, Rennes University Hospital, 2, rue Henri Le Guilloux, 35033, Rennes Cedex, France.
  • Ronney Abaza
    OhioHealth Robotic Urologic and Cancer Surgery, Dublin Methodist Hospital, Dublin, Ohio.
  • Ketan K Badani
    Department of Urology, Icahn School of Medicine at Mount Sinai Hospital , New York, New York.
  • Reza Mehrazin
    Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Maurizio Buscarini
    Department of Urology, The University of Tennessee Health Science Center, Memphis, TN, USA.
  • Alessandro Larcher
    Division of Oncology, Unit of Urology, IRCCS Ospedale San Raffaele, Milan, Italy.